Investor Overview

Company Profile

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney disease and acute ischemic stroke. DiaMedica's shares are listed on The Nasdaq Capital Market under the trading symbol "DMAC."

-

Nasdaq Stock Snapshot

DMAC Symbol
Nasdaq Market
-- Volume
-- Price
-- Change
Go to Detailed Stock Information ›

Upcoming Events

DM199 CKD Phase Ib Interim Results and Phase II Overview Conference Call

Listeners should log on to the website or dial in 15 minutes prior to the call. 

Date:  Thursday, June 20, 2019
Time: 7:00 AM CT
Web access: https://edge.media-server.com/m6/p/78quvxo3
Dial In: (866) 962-3583 (domestic)
(630) 652-5857 (international)
Conference ID: 1746669

A telephonic replay of the conference call will be available until June 27, 2019, by dialing 1(855) 859-2056 (US Toll Free Dial In), (404) 537-3406 (international), replay passcode 1746669.

An archived replay of the webcast will be available on the Company’s website for 90 days after the call.

View Events ›